Drivers of leukemogenesis in congenital neutropenias
EHA Learning Center, Karl Welte, 184408
Molecular profiling of indolent lymphoma
EHA Learning Center, STEFANO PILERI, 184392
Molecular genetics in MPN
EHA Learning Center, Alessandro M. Vannucchi, 184396
Balance of efficacy vs toxicity in treatment of childhood ALL: Time for dose reductions?
EHA Learning Center, Ajay Vora, 184400
Diagnosis of inherited bone marrow failure and myelodysplastic syndromes
EHA Learning Center, Akiko Shimamura, 184404
EHA22 Educational Updates in Hematology
EHA Learning Center, EHA annual congress, 186248
Syndromes predisposing to hematological malignancies
EHA Learning Center, Christian Kratz, 185019
Diagnosis of inherited bone marrow failure and myelodysplastic syndromes
EHA Learning Center, Akiko Shimamura, 185020
The 100.000 Genomes Project
EHA Learning Center, Willem Ouwehand, 185021
The role of the microenvironment in the pathogenesis of B-cell lymphomas
EHA Learning Center, Georg Lenz, 185022
Immune checkpoint inhibitors
EHA Learning Center, Anas Younes, 185023
Is transplantation in lymphoma still needed in the era of immunotherapy?
EHA Learning Center, Anna Sureda, 185024
Novel approaches to eradicate CML stem cells
EHA Learning Center, Mhairi Copland, 185025
Molecular work up and monitoring of CML patients
EHA Learning Center, Nick Cross, 185026
How to treat CML in 2017
EHA Learning Center, Andreas Hochhaus, 185027
GvHD prophylaxis and treatment, new modalities
EHA Learning Center, Robert Zeiser, 185028
The role of the intestinal microbiota in graft-versus-host disease
EHA Learning Center, Marcel van den Brink, 185029
Balancing Graft versus Leukemia and Graft versus Host responses
EHA Learning Center, Fred Falkenburg, 185030
Genome editing in hemoglobinopathies
EHA Learning Center, Mitch Weiss, 185031
Iron chelation in hemoglobinopathies
EHA Learning Center, Vip Viprakasit, 185032
Neurological complications of sickle cell disease
EHA Learning Center, Fenalla Kirkham, 185033
Biological and clinical relevance of fibrin clot structure
EHA Learning Center, Nicola Mutch, 185034
Diagnosis and management of DIC and primary hyperfibrinolysis
EHA Learning Center, Alessandro Squizzato, 185035
Rare bleeding disorders - Diagnosis and treatment
EHA Learning Center, Gili Kenet, 185036
Relevance of the microenvironment in CLL
EHA Learning Center, Federico Caligaris-Cappio, 185037
Prognostic factors in chronic lymphocytic leukemia: When, which and how?
EHA Learning Center, Sarka Pospisilova, 185038
Prioritizing therapies in CLL
EHA Learning Center, Clemens Wendtner, 185039
The effects of chemotherapy and radiotherapy on reproduction
EHA Learning Center, William Hamish Wallace, 185040
Fertility preservation in female patients
EHA Learning Center, Marie-Madeline Dolmans, 185041
Fertility preservation in pre-pubertal and adult males
EHA Learning Center, Rod Mitchell, 185042
Cross-talk between inflammation and coagulation
EHA Learning Center, Thomas Renné, 185043
Novel aspects in the diagnostic management of deep vein thrombosis and pulmonary embolism
EHA Learning Center, Menno Huisman, 185044
Controversies in treating small clots in the leg and in the lung
EHA Learning Center, Sebastian Schellong, 185045
Clonal evolution in MDS
EHA Learning Center, Joop Jansen, 185046
The role of immune response in MDS pathophysiology
EHA Learning Center, Ghulam Mufti, 185047
Indications for transplantation in myelodysplastic syndromes (MDS)
EHA Learning Center, Matteo Giovanni Della Porta, 185048
Molecular diagnostics in AML
EHA Learning Center, Lars Bullinger, 185049
Targeting mutated FLT3 in AML
EHA Learning Center, Mark Levis, 185050
3+7 and beyond
EHA Learning Center, Norbert Vey, 185051
Cell-derived microvesicles/microparticles in blood components: Consequences for transfusion recipients
EHA Learning Center, Thierry Burnouf, 185052
Challenges in typing and matching strategies in patients with hematological malignancies in the era of immunotherapy
EHA Learning Center, Karen Vooght, 185053
Red blood cell transfusion: When to transfuse in patients with hematological malignancies?
EHA Learning Center, Miguel Lozano Molero, 185054
Transferrin and TfR1 in co-regulation of erythropoiesis and iron metabolism
EHA Learning Center, Yelena Ginzburg, 185055
Iron overload before, during and after bone marrow transplantation
EHA Learning Center, Emanuele Angelucci, 185056
Heat Shock Protein 70 (HSP70), one of the major key factors in Diamond-Blackfan anemia
EHA Learning Center, Lydie Da Costa, 185057
The biological basis of aggressive lymphoma
EHA Learning Center, Elias Campo, 185058
Relapsed aggressive lymphoma: Can we optimize the therapy
EHA Learning Center, Gilles Salles, 185059
Treatment of aggressive lymphomas focused on elderly patients
EHA Learning Center, Michael Pfreundschuh, 185060
Immunopathology of multiple myeloma
EHA Learning Center, Nikhil Munshi, 185061
Genetic classification of myeloma for prognostication and treatment selection
EHA Learning Center, Hervé Avet-Loiseau, 185062
New approaches to myeloma treatment in 2017
EHA Learning Center, Jesus F. San Miguel, 185063
Molecular profiling of indolent lymphoma
EHA Learning Center, STEFANO PILERI, 185010
Update on follicular lymphoma: Time beyond chemotherapy?
EHA Learning Center, Kai Hübel, 185011
Treatment of extranodal marginal zone B-cell lymphomas (MALT-lymphomas)
EHA Learning Center, Markus Raderer, 185012
Molecular genetics in MPN
EHA Learning Center, Alessandro M. Vannucchi, 185013
Targeting specific mutations in myeloproliferative neoplasms
EHA Learning Center, Ann Mullally, 185014
Emerging treatments for classical myeloproliferative neoplasms
EHA Learning Center, Claire Harrison, 185015
Balancing efficacy and toxicity in the treatment of childhood ALL
EHA Learning Center, Ajay Vora, 185016
Immunotherapy for ALL: From biology to the clinic and back
EHA Learning Center, Terry Fry, 185017
Novel approaches with recently licensed drugs or recently studied in relapsed ALL
EHA Learning Center, Jose Maria Ribera, 185018
EHA22 Abstract Book
EHA Learning Center, EHA annual congress, 184712
Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
EHA Learning Center, Anna Oberle, 184576
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome
EHA Learning Center, Zhanna SHEKHOVTSOVA, 184577
Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality
EHA Learning Center, Sachiko Seo, 184578
Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks
EHA Learning Center, Hanadi Rafii, 184562
Histone deacetylase 6 regulates cytokinesis and erythrocyte enucleation through deacetylation of formin protein mDia2
EHA Learning Center, Xuehui Li, 184563
Cdk6 contributes to cytoskeletal stability in erythroid cells
EHA Learning Center, Iris Uras, 184564
Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features
EHA Learning Center, Paul Saultier, 184565
An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia
EHA Learning Center, Yuan Zhou, 184566
Molecular features of early onset adult myelodysplastic syndrome
EHA Learning Center, Cassandra Hirsch, 184567
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
EHA Learning Center, Mohamad Jawhar, 184568
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
EHA Learning Center, Chien-Chin Lin, 184569
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
EHA Learning Center, Maura Gasparetto, 184570
Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT
EHA Learning Center, Jonathan Canaani, 184571
Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia
EHA Learning Center, Owen McGinn, 184572
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications
EHA Learning Center, Shang-Ju Wu, 184573
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
EHA Learning Center, Marius Rohde, 184574
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
EHA Learning Center, Miquel Granell, 184575
Interpreting recent updates on AML and low risk MDS for daily clinical practice
EHA Learning Center, Delivered by Janssen, 183902
SECONDARY CHROMOSOMAL ABNORMALITIES AND THEIR IMPACT ON TREATMENT OUTCOME IN PEDIATRIC BURKITT LEUKEMIA.
EHA Learning Center, Sherine Ibrahim Salem, 182784
CLINICAL SIGNIFICANCE OF ELEVATED SERUM COBALAMIN (VITAMIN B12) LEVELS
EHA Learning Center, Selin Aytac, 182800
LONG-TERM EFFICACY AND SAFETY OF THROMBOPOIETIN AGONISTS IN ADULT REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA
EHA Learning Center, Eleni Gavriilaki, 182816
THROMBOPOIETIN-RECEPTOR AGONISTS IN ITP - EXPERIENCE OF A CENTER
EHA Learning Center, Maria Teles, 182832
TARGETED MUTATIONAL PROFILING OF CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Learning Center, Natasa Tosic, 182326
IMPACT OF U.S. FDA APPROVAL OF LENALIDOMIDE MAINTENANCE THERAPY IN THE FIRST-LINE TREATMENT OF MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT ON TOTAL HEALTHCARE COSTS
EHA Learning Center, Safiya Abouzaid, 182848
DELAYED HAEMOLYTIC TRANSFUSION REACTIONS (DHTR): A MASQUERADE OF SICKLE CELL COMPLICATIONS
EHA Learning Center, Harberth Fernandez - Leyva, 182864
RAPID RECONSTITUTION OF NK1 CELLS IS ASSOCIATED WITH THE LOWER INCIDENCE OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC TRANSPLANTATION
EHA Learning Center, Xiao-jun Huang, 182880
MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN REAL-LIFE EXPERIENCE: AN UPDATE FROM RECAMDS
EHA Learning Center, Claudio Cerchione, 182637
SAFETY AND EFFICACY OF TBF CONDITIONING IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION.A RETROSPECTIVE SINGLE CENTER EXPERIENCE.
EHA Learning Center, Radwan Massoud, 182896
SILENCE OF LONG NONCODING RNA MALAT1 BY RNA INTERFERENCE INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN MULTIPLE MYELOMA
EHA Learning Center, Zuofei Chi, 182653
THALASSEMIA IN MADRID: A PICTURE OF THE CURRENT SITUATION
EHA Learning Center, Eduardo J. Bardón-Cancho, 182913
A PHASE III RANDOMIZED, OPEN-LABEL STUDY OF ISATUXIMAB (SAR650984) PLUS POMALIDOMIDE (POM) AND DEXAMETHASONE (DEX) VERSUS POM AND DEX IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Learning Center, Paul Richardson, 182671
THE PRINCIPAL COMPONENT ANALYSIS USING CALIBRATED AUTOMATED THROMBOGRAM PARAMETERS AS A POTENTIAL QUALITY CONTROL FOR MEASURING PROCOAGULANT ACTIVITIES OF IMMUNOGLOBULINS
EHA Learning Center, Hokyung Oh, 182931
FEASIBILITY/PHASE II STUDY OF MYELOABLATIVE BEAM ALLOGENEIC TRANSPLANTATION FOLLOWED BY ORAL IXAZOMIB MAINTENANCE THERAPY IN PATIENTS WITH HIGH RISK MYELOMA
EHA Learning Center, Emma Scott, 182687
EFFICACY AND INFLUENCE OF IRON CHELATION THERAPY ON RED BLOOD CELL TRANSFUSIONS
EHA Learning Center, Andrada Viorica Parvu, 182947
DETECTING EARLY RELAPSE IN MULTIPLE MYELOMA (MM) AFTER ASCT: USEFULNESS OF IMMUNEASSAYS.
EHA Learning Center, Marcio Andrade-Campos, 182703
MOLECULAR GENETIC CRITERIA PREDICTING THE EFFICIENCY OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
EHA Learning Center, Tetiana Liubarets, 182719
IMWG ´14 DIAGNOSTIC CRITERIA TO INITIATE TREATMENT IN NEW DIAGNOSED MULTIPLE MYELOMA (NDMM): REAL-WORLD STADISTICS
EHA Learning Center, Fernando Escalante, 182735
IN JAK2V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS, BLEEDING RISK CORRELATES WITH ALLELE BURDEN
EHA Learning Center, Irene Bertozzi, 182751
JAK2, CALR AND MPL MUTATIONS: CORRELATION WITH PHENOTIPE DISEASE AND HISTOPATHOLOGICAL FEATURES OF BONE BIOPSY
EHA Learning Center, Heidy Johana Campo Palacio, 182768